Dr. rer. nat. Arif Bülent Ekici

Institute of Human Genetics

Differential Effects of Ontamalimab Versus Vedolizumab on Immune Cell Trafficking in Intestinal Inflammation and Inflammatory Bowel Disease (2023) Schulze L, Becker E, Dedden M, Liu L, Van Passen C, Mohamed Abdou M, Müller T, et al. Journal article Differential Effects of Very-Low-Volume Exercise Modalities on Telomere Length, Inflammation, and Cardiometabolic Health in Obese Metabolic Syndrome Patients: A Subanalysis from Two Randomized Controlled Trials (2023) Reljic D, Koller A, Herrmann HJ, Ekici AB, Neurath M, Zopf Y Journal article ALS is imprinted in the chromatin accessibility of blood cells (2023) Kühlwein JK, Ruf WP, Kandler K, Witzel S, Lang C, Mulaw MA, Ekici AB, et al. Journal article CRISPR/Cas9-mediated generation of hESC lines with homozygote and heterozygote p.R331W mutation in CTBP1 to model HADDTS syndrome (2023) Akdas EY, Turan S, Guhathakurta D, Ekici AB, Salar S, Lie DC, Winner B, Fejtová A Journal article, Original article Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells (2023) Enders M, Weier A, Chunder R, An Y, Bremm F, Feigenspan A, Büttner C, et al. Journal article Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis (2023) Fu Z, Brooks MM, Irvin S, Jordan S, Aben KKH, Anton-Culver H, Bandera E, et al. Journal article Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. (2023) Mackensen A, Müller F, Mougiakakos D, Böltz S, Wilhelm A, Aigner M, Völkl S, et al. Journal article, Erratum NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases (2023) Weber S, Sitte S, Vögele AL, Sologub L, Wilfer A, Rath T, Nägel A, et al. Journal article Tumor microenvironment-dependent epigenetic imprinting in the vasculature predicts colon cancer outcome (2023) Naschberger E, Fuchs M, Dickel N, Kunz M, Popp B, Anchang CG, Demmler R, et al. Journal article IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells. (2023) Ullrich K, Derdau J, Baltes C, Battistella A, Rosso G, Uderhardt S, Schulze L, et al. Journal article